AI:EURONEXT PARISAir Liquide SA Analysis
Data as of 2026-07-02 - not real-time
$9.06
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading near its recent support level while the short‑term moving average remains above the longer‑term average, suggesting a tenuous neutral stance. Momentum indicators show the RSI hovering in the lower‑mid range, implying limited buying pressure. The MACD histogram is negative and the line sits below its signal, reinforcing a bearish short‑term bias. Daily volume has been trending lower, which may diminish price resilience on downside moves. Market sentiment is currently dominated by extreme greed, a condition that can exacerbate price swings in a volatile environment. On the fundamentals side, the company reports negative earnings per share and operating losses, indicating profitability challenges.
Gross margins are modest, while operating cash flow remains negative, highlighting ongoing cash generation concerns. The balance sheet shows a modest cash reserve that slightly exceeds total debt, but the debt‑to‑equity ratio is elevated. Valuation multiples are high relative to sales and book value, and the forward price‑to‑earnings projection is negative, pointing to an overvalued pricing scenario. The firm operates in a high‑beta, high‑volatility technology segment, which amplifies systematic risk. Regulatory scrutiny of artificial intelligence applications is increasing, adding a layer of uncertainty to the business outlook. Given the blend of weak earnings, elevated risk metrics, and a market environment marked by speculative enthusiasm, the stock warrants a cautious approach.
Gross margins are modest, while operating cash flow remains negative, highlighting ongoing cash generation concerns. The balance sheet shows a modest cash reserve that slightly exceeds total debt, but the debt‑to‑equity ratio is elevated. Valuation multiples are high relative to sales and book value, and the forward price‑to‑earnings projection is negative, pointing to an overvalued pricing scenario. The firm operates in a high‑beta, high‑volatility technology segment, which amplifies systematic risk. Regulatory scrutiny of artificial intelligence applications is increasing, adding a layer of uncertainty to the business outlook. Given the blend of weak earnings, elevated risk metrics, and a market environment marked by speculative enthusiasm, the stock warrants a cautious approach.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- bearish MACD signal
- declining volume
- support near current price
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- ongoing operating losses
- high volatility
- uncertain regulatory environment
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- strategic cloud partnerships
- potential AI adoption growth
- cash cushion exceeds debt
Key Metrics & Analysis
Financial Health
Revenue Growth-52.50%
Profit Margin-187.95%
P/E Ratio-20.1
ROE-63.05%
ROA-33.09%
Debt/Equity8.98
P/B Ratio2.1
Op. Cash Flow$-190228000
Free Cash Flow$-26476750
Industry P/E36.0
Technical Analysis
TrendNeutral
RSI40.9
Support$8.50
Resistance$11.36
MA 20$10.04
MA 50$9.67
MA 200$12.39
MACDBearish
VolumeDecreasing
Fear & Greed Index92.59
Valuation
Target Price$8.82
Upside/Downside-2.67%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.39
Volatility60.99%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.